Unknown OBSERVATIONAL NCT03291236

Survival Outcomes of Uterine Cervical Malignancies in Chinese Population

Sponsor: Lei Li

Conditions Survival Uterine Cervical Neoplasms

Interventions Follow-up for death and recurrence of patients

Updated 9 times since 2017 Last updated: Feb 7, 2018 Started: Jan 1, 2017 Primary completion: Jan 1, 2022 Completion: Jan 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03291236, this observational or N/A phase trial focuses on Survival and Uterine Cervical Neoplasms and remains ongoing. Sponsored by Lei Li, it has been updated 9 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2023 [monthly]

Recruiting
Aug 2018 — Jan 2021 [monthly]

Recruiting

▶ Show 4 earlier versions

Jul 2018 — Aug 2018 [monthly]

Recruiting
Jun 2018 — Jul 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lei Li

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China